139 related articles for article (PubMed ID: 11718598)
1. PDR provides latest Food and Drug Administration-approved dosage guidelines.
Mehta M
Arch Intern Med; 2001 Nov; 161(21):2622; author reply 2623. PubMed ID: 11718598
[No Abstract] [Full Text] [Related]
2. Cohen vs. PDR.
Rohde RA
Arch Intern Med; 2001 Nov; 161(21):2622-3; author reply 2623. PubMed ID: 11718599
[No Abstract] [Full Text] [Related]
3. FDA approves i.v. calcium-channel blocker.
Thompson CA
Am J Health Syst Pharm; 2008 Sep; 65(18):1686. PubMed ID: 18768991
[No Abstract] [Full Text] [Related]
4. Intravenous to oral conversion of antihypertensives: a toolkit for guideline development.
Dasta JF; Boucher BA; Brophy GM; Cohen H; Hassan E; Maclaren R; Muzykovsky K; Martin SJ; Pass SE; Seybert AL
Ann Pharmacother; 2010 Sep; 44(9):1430-47. PubMed ID: 20702758
[TBL] [Abstract][Full Text] [Related]
5. Trough/peak ratios for antihypertensive agents. The issues in perspective.
Meredith PA
Drugs; 1994 Nov; 48(5):662-6. PubMed ID: 7530624
[No Abstract] [Full Text] [Related]
6. Adverse drug effects, compliance, and initial doses of antihypertensive drugs recommended by the Joint National Committee vs the Physicians' Desk Reference.
Cohen JS
Arch Intern Med; 2001 Mar; 161(6):880-5. PubMed ID: 11268233
[TBL] [Abstract][Full Text] [Related]
7. How many antihypertensives do patients need to achieve a target blood pressure?
Marshall T
J Hum Hypertens; 2005 Apr; 19(4):317-9. PubMed ID: 15660116
[No Abstract] [Full Text] [Related]
8. Drugs for hypertension.
Med Lett Drugs Ther; 1999 Mar; 41(1048):23-8. PubMed ID: 10092931
[No Abstract] [Full Text] [Related]
9. Some problems with antihypertensive drug studies in the context of the new guidelines.
Rose M; McMahon FG
Am J Hypertens; 1990 Feb; 3(2):151-5. PubMed ID: 2407266
[TBL] [Abstract][Full Text] [Related]
10. Discrepant antihypertensive dose recommendations.
Milic M; Ziegler MG
Clin Exp Hypertens; 2006 Feb; 28(2):171-80. PubMed ID: 16546842
[TBL] [Abstract][Full Text] [Related]
11. The United States Food and Drug Administration guidelines on ambulatory blood pressure monitoring.
Lipicky R
J Hypertens Suppl; 1991 Dec; 9(8):S59. PubMed ID: 1795204
[TBL] [Abstract][Full Text] [Related]
12. Management of hypertension in the young: role of antihypertensive medications.
Flynn JT
J Cardiovasc Pharmacol; 2011 Aug; 58(2):111-20. PubMed ID: 21242810
[TBL] [Abstract][Full Text] [Related]
13. FDA guidelines on trough: peak ratios in the evaluation of antihypertensive agents. United States Food and Drug Administration.
Meredith PA; Elliott HL
J Cardiovasc Pharmacol; 1994; 23 Suppl 5():S26-30. PubMed ID: 7609502
[TBL] [Abstract][Full Text] [Related]
14. Hypertension: a review of therapeutic options.
Carter BL
Manag Care; 2003 Aug; 12(8 Suppl Hypertension):34-44. PubMed ID: 12971591
[TBL] [Abstract][Full Text] [Related]
15. 'Off-label' prescribing, the Physician's Desk Reference and the court.
Spector RA; Marquez E
J La State Med Soc; 2011; 163(5):276-80. PubMed ID: 22272550
[TBL] [Abstract][Full Text] [Related]
16. [Revised guidelines for antihypertensive treatment. What is relevant for the general practitioner?].
Zidek W
MMW Fortschr Med; 2004 Jan; 146(1-2):37-8. PubMed ID: 18437867
[No Abstract] [Full Text] [Related]
17. Trandolapril approved for marketing.
Am J Health Syst Pharm; 1996 Jul; 53(14):1649. PubMed ID: 8827227
[No Abstract] [Full Text] [Related]
18. [American hypertension guidelines discussed. Are diuretics really the best first-line therapy?].
MMW Fortschr Med; 2003 Aug; 145(31-32):50. PubMed ID: 14524075
[No Abstract] [Full Text] [Related]
19. Role of trough to peak efficacy in the evaluation of antihypertensive therapy.
Meredith PA
J Hypertens Suppl; 1998 Jan; 16(1):S59-64. PubMed ID: 9534099
[TBL] [Abstract][Full Text] [Related]
20. Trough: peak ratio: the rationale behind the United States Food and Drug Administration recommendations.
Lipicky RJ
J Hypertens Suppl; 1994 Nov; 12(8):S17-8; discussion S18-9. PubMed ID: 7707150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
